Esophagogastric adenocarcinoma

Clinical trials for Esophagogastric adenocarcinoma explained in plain language.

Never miss a new study

Get alerted when new Esophagogastric adenocarcinoma trials appear

Sign up with your email to follow new studies for Esophagogastric adenocarcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1 Completed 2 Terminated 1

New combo therapy aims to shrink HER2+ stomach tumors before surgery

Disease control Ongoing

This study tests whether combining the targeted drug trastuzumab-deruxtecan with other treatments before surgery is safe and feasible for people with HER2-positive stomach or esophagus cancer that has not spread. About 36 adults will receive the drug combinations before their pla…

Matched conditions: ESOPHAGOGASTRIC ADENOCARCINOMA

Phase 1/2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control

Last updated Jun 27, 2026 12:23 UTC

Esophagogastric adenocarcinoma

Get alerted when new Esophagogastric adenocarcinoma trials appear

New combo therapy aims to shrink HER2+ stomach tumors before surgery